Trial Profile
A Randomized, Double Blind, Multiple Dose, Cross-Over, Placebo- and Active-Controlled Proof of Concept Study to Explore the Effects of AFQ056 and Nicotine (Active Comparator) on Craving and Withdrawal During Voluntary Smoking Abstinence in Healthy Smokers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2014
Price :
$35
*
At a glance
- Drugs Mavoglurant (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Proof of concept; Therapeutic Use
- Sponsors Novartis
- 16 Sep 2014 New trial record